Recent Developments

Life Technologies Corporation develops, manufactures, and supplies the goods utilized in life science research. The Company deliveries sera and other cell growth media, enzymes and other biological products essential for recombinant DNA processes. Life Technologies assists consumers throughout the United States.

Life Technologies is a biotech company, which has launched Lipofectamine, lipid-based formulations for nucleic acid delivery, it increases cell viability and reproducibility during transfection procedure of hard to transfect cell lines by virtue of optimization in several steps of transfection.

To know more, read @ https://www.marketdataforecast.com/market-reports/transfection-reagents-and-equipment-market-3217/

Market Segmentation:

Market Data Forecast published a report named Transfection Reagents and Equipment Market. The Global Transfection Reagents and Equipment market worth was USD 826.73 million in 2018. It was estimated to reach at a CAGR of 7.5 % to reach USD 1186.88 billion by 2023.

Report segmented as:

By Product:

• Reagents

• Instruments

• Method

• Biochemical

• Calcium Phosphate

• Physical

• Electroporation

• Nucleofection

By Application:

• Biomedical Research

• Protein Production

• Therapeutic Delivery

The high price of transfection reagents and equipment, risk aspects during insertion of the reagents and cytotoxic effect related to transfection technology are the key aspects limiting the current transfection reagents and equipment market

Geographical Segmentation:

Based on geography, the market divided under many countries North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America has expected to have the highest share.

Key Market Players:

• Thermo Fisher Scientific Inc. (U.S.)

• Hoffmann-La Roche Ltd. (Switzerland)

• Polyplus-transfection SA (France)

• Bio-Rad Laboratories (U.S.)

• Promega Corporation (U.S.)

• Mirus Bio LLC (U.S.)

• QIAGEN N.V. (Netherlands)

• Lonza Group (Switzerland)

• Sigma-Aldrich Corporation (U.S.)

• MaxCyte Inc. (U.S.)

View a sample and decide @ https://www.marketdataforecast.com/market-reports/transfection-reagents-and-equipment-market-3217/request-sample

The Scope of the report:

The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed and the prospects with huge growth potential identified and debated.

The key players in the industry are profiled giving insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry had provided. The report also provides a broad outlook of the current market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.